Literature DB >> 21309960

Innate difference in the endocannabinoid signaling and its modulation by alcohol consumption in alcohol-preferring sP rats.

K Yaragudri Vinod1, Paola Maccioni, Maria Salud Garcia-Gutierrez, Teresa Femenia, Shan Xie, Mauro A M Carai, Jorge Manzanares, Thomas B Cooper, Basalingappa L Hungund, Giancarlo Colombo.   

Abstract

The present study was undertaken to examine whether genetically predetermined differences in components of the endocannabinoid system were present in the brain of Sardinian alcohol-preferring (sP) and Sardinian alcohol-non-preferring (sNP) rats, a pair of rat lines selectively bred for opposite alcohol preference. The effects of acquisition and maintenance of alcohol drinking, alcohol withdrawal, and alcohol re-exposure on the endocannabinoid system was also assessed in the striatum of sP rats. The findings revealed significantly higher density of the CB1 receptors and levels of CB1 receptor mRNA, CB1 receptor-mediated G-protein coupling, and endocannabinoids in the cerebral cortex, hippocampus and striatum of alcohol-naive sP rats than sNP rats. A significantly lower expression of mFAAH enzyme was evident in the hippocampus of alcohol-naive sP rats. Alcohol drinking (during both acquisition and maintenance phases) in sP rats resulted in a significant reduction in striatal CB1 receptor-mediated G-protein coupling whereas alcohol withdrawal attenuated this effect. Alcohol consumption was also associated with markedly increased levels of endocannabinoids in the striatum. Co-administration of the CB1 receptor antagonist, rimonabant (SR141716A) reduced alcohol intake, and reversed alcohol-induced changes in CB1 receptor-mediated G-protein activation. These findings provided a new insight into a potential genetic basis of excessive alcohol consumption, suggesting innate differences in the endocannabinoid system might be associated with higher alcohol preference in sP rats. The data also indicate a modulation of CB1 receptor-mediated signaling following alcohol consumption, and further strengthen the potential of the endocannabinoid system as a target for the treatment of alcohol related behaviors.
© 2011 The Authors, Addiction Biology © 2011 Society for the Study of Addiction.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21309960      PMCID: PMC3135767          DOI: 10.1111/j.1369-1600.2010.00299.x

Source DB:  PubMed          Journal:  Addict Biol        ISSN: 1355-6215            Impact factor:   4.280


  43 in total

1.  The cannabinoid receptor antagonist SR 141716 prevents acquisition of drinking behavior in alcohol-preferring rats.

Authors:  S Serra; M A Carai; G Brunetti; R Gomez; S Melis; G Vacca; G Colombo; G L Gessa
Journal:  Eur J Pharmacol       Date:  2001-11-02       Impact factor: 4.432

2.  Ethanol, endocannabinoids, and the cannabinoidergic signaling system.

Authors:  Basalingappa L Hungund; Balapal S Basavarajappa; Csaba Vadasz; George Kunos; Fernando Rodriguez de Fonseca; Giancarlo Colombo; Salvatore Serra; Loren Parsons; George F Koob
Journal:  Alcohol Clin Exp Res       Date:  2002-04       Impact factor: 3.455

Review 3.  Blockade of the cannabinoid CB1 receptor and alcohol dependence: preclinical evidence and preliminary clinical data.

Authors:  Paola Maccioni; Giancarlo Colombo; Mauro A M Carai
Journal:  CNS Neurol Disord Drug Targets       Date:  2010-03       Impact factor: 4.388

4.  Effects of SR141716A on ethanol and sucrose self-administration.

Authors:  C S Freedland; A L Sharpe; H H Samson; L J Porrino
Journal:  Alcohol Clin Exp Res       Date:  2001-02       Impact factor: 3.455

5.  Different sensitivity to ethanol in alcohol-preferring sP and -nonpreferring sNP rats.

Authors:  G Colombo; R Agabio; M A Carai; C Lobina; M Pani; R Reali; G Vacca; G L Gessa
Journal:  Alcohol Clin Exp Res       Date:  2000-11       Impact factor: 3.455

6.  Blockade by the cannabinoid CB(1) receptor antagonist, SR 141716, of alcohol deprivation effect in alcohol-preferring rats.

Authors:  Salvatore Serra; Giuliana Brunetti; Marialaura Pani; Giovanni Vacca; Mauro A M Carai; Gian Luigi Gessa; Giancarlo Colombo
Journal:  Eur J Pharmacol       Date:  2002-05-17       Impact factor: 4.432

7.  Chronic exposure to morphine, cocaine or ethanol in rats produced different effects in brain cannabinoid CB(1) receptor binding and mRNA levels.

Authors:  Sara Gonzalez; Javier Fernandez-Ruiz; Valentina Sparpaglione; Daniela Parolaro; Jose A Ramos
Journal:  Drug Alcohol Depend       Date:  2002-03-01       Impact factor: 4.492

8.  Endocannabinoid signaling via cannabinoid receptor 1 is involved in ethanol preference and its age-dependent decline in mice.

Authors:  Lei Wang; Jie Liu; Judith Harvey-White; Andreas Zimmer; George Kunos
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-21       Impact factor: 11.205

9.  Cannabinoid CB1 receptor knockout mice exhibit markedly reduced voluntary alcohol consumption and lack alcohol-induced dopamine release in the nucleus accumbens.

Authors:  Basalingappa L Hungund; Istvan Szakall; Agota Adam; Balapal S Basavarajappa; Csaba Vadasz
Journal:  J Neurochem       Date:  2003-02       Impact factor: 5.372

10.  Changes in endocannabinoid contents in the brain of rats chronically exposed to nicotine, ethanol or cocaine.

Authors:  Sara González; Maria Grazia Cascio; Javier Fernández-Ruiz; Filomena Fezza; Vincenzo Di Marzo; José A Ramos
Journal:  Brain Res       Date:  2002-11-01       Impact factor: 3.252

View more
  21 in total

Review 1.  Endocannabinoid influence in drug reinforcement, dependence and addiction-related behaviors.

Authors:  Antonia Serrano; Loren H Parsons
Journal:  Pharmacol Ther       Date:  2011-07-18       Impact factor: 12.310

Review 2.  Rat animal models for screening medications to treat alcohol use disorders.

Authors:  Richard L Bell; Sheketha R Hauser; Tiebing Liang; Youssef Sari; Antoniette Maldonado-Devincci; Zachary A Rodd
Journal:  Neuropharmacology       Date:  2017-02-16       Impact factor: 5.250

3.  Cannabinoid-1 receptor neutral antagonist reduces binge-like alcohol consumption and alcohol-induced accumbal dopaminergic signaling.

Authors:  Andrea Balla; Bin Dong; Borehalli M Shilpa; Kiran Vemuri; Alexandros Makriyannis; Subhash C Pandey; Henry Sershen; Raymond F Suckow; K Yaragudri Vinod
Journal:  Neuropharmacology       Date:  2017-11-03       Impact factor: 5.250

4.  Chronic ethanol exposure decreases CB1 receptor function at GABAergic synapses in the rat central amygdala.

Authors:  Florence P Varodayan; Neeraj Soni; Michal Bajo; George Luu; Samuel G Madamba; Paul Schweitzer; Loren H Parsons; Marisa Roberto
Journal:  Addict Biol       Date:  2015-05-05       Impact factor: 4.280

5.  Enhanced endocannabinoid-mediated modulation of rostromedial tegmental nucleus drive onto dopamine neurons in Sardinian alcohol-preferring rats.

Authors:  Miriam Melis; Claudia Sagheddu; Marta De Felice; Alberto Casti; Camilla Madeddu; Saturnino Spiga; Anna Lisa Muntoni; Kenneth Mackie; Giovanni Marsicano; Giancarlo Colombo; Maria Paola Castelli; Marco Pistis
Journal:  J Neurosci       Date:  2014-09-17       Impact factor: 6.167

6.  Lower brain fatty acid amide hydrolase in treatment-seeking patients with alcohol use disorder: a positron emission tomography study with [C-11]CURB.

Authors:  Laura M Best; Belinda Williams; Bernard Le Foll; Esmaeil Mansouri; Richard P Bazinet; Lin Lin; Vincenzo De Luca; Dina Lagzdins; Pablo Rusjan; Rachel F Tyndale; Alan A Wilson; Christian S Hendershot; Markus Heilig; Sylvain Houle; Junchao Tong; Stephen J Kish; Isabelle Boileau
Journal:  Neuropsychopharmacology       Date:  2020-01-07       Impact factor: 7.853

Review 7.  Roles for the endocannabinoid system in ethanol-motivated behavior.

Authors:  Angela N Henderson-Redmond; Josée Guindon; Daniel J Morgan
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2015-06-26       Impact factor: 5.067

8.  Transient changes in the endocannabinoid system after acute and chronic ethanol exposure and abstinence in the rat: a combined PET and microdialysis study.

Authors:  Jenny Ceccarini; Cindy Casteels; Michel Koole; Guy Bormans; Koen Van Laere
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-06-06       Impact factor: 9.236

Review 9.  Endocannabinoid Signaling in the Central Amygdala and Bed Nucleus of the Stria Terminalis: Implications for the Pathophysiology and Treatment of Alcohol Use Disorder.

Authors:  Gaurav Bedse; Samuel W Centanni; Danny G Winder; Sachin Patel
Journal:  Alcohol Clin Exp Res       Date:  2019-08-21       Impact factor: 3.455

Review 10.  Animal models for medications development targeting alcohol abuse using selectively bred rat lines: neurobiological and pharmacological validity.

Authors:  Richard L Bell; Helen J K Sable; Giancarlo Colombo; Petri Hyytia; Zachary A Rodd; Lawrence Lumeng
Journal:  Pharmacol Biochem Behav       Date:  2012-07-25       Impact factor: 3.533

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.